ArticleAmerican journal of hematology2025

Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.

Giovanni Marconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.